Condition
PSMA PET-Positive Castration-Resistant Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 PSMA PET-Positive Castration-Resistant Prostate Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Finland (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Observational study on Lutetium-177 treatment for metastatic prostate cancer
This study is testing if Lutetium-177 treatment can help men with advanced prostate cancer feel better and understand how their bodies respond to the therapy.
-
Evaluating a new treatment for advanced prostate cancer
This study is testing a new radioantibody treatment for advanced prostate cancer to see how safe it is and what the best dose might be for patients with a specific type of the disease.
Related topics
Quick answers
How many PSMA PET-Positive Castration-Resistant Prostate Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Finland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.